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F-92265 Fontenay-aux-Roses, France, 3Université Paris Diderot, UMR 967, F-92265 Fontenay-aux-Roses, France,
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ABSTRACT
The prion protein (PrP) is highly conserved and
ubiquitously expressed, suggesting that it plays an
important physiological function. However, despite
decades of investigation, this role remains elusive.
Here, by using animal and cellular models, we un-
veil a key role of PrP in the DNA damage response.
Exposure of neurons to a genotoxic stress activates
PRNP transcription leading to an increased amount
of PrP in the nucleus where it interacts with APE1, the
major mammalian endonuclease essential for base
excision repair, and stimulates its activity. Prevent-
ing the induction of PRNP results in accumulation
of abasic sites in DNA and impairs cell survival af-
ter genotoxic treatment. Brains from Prnp−/− mice
display a reduced APE1 activity and a defect in the
repair of induced DNA damage in vivo. Thus, PrP is
required to maintain genomic stability in response to
genotoxic stresses.
INTRODUCTION
PrPScr, a conformational isoform of the prion protein PrP,
is well known for its role as an infectious agent in a series
of fatal neurodegenerative diseases characterized by exten-
sive brain spongiform degeneration, widespread neuronal
loss, synaptic alteration and atypical brain inflammation.
However, the physiological role of PrP remains elusive. Its
high degree of conservation suggests that it has an impor-
tant function (1–3). The demonstration that transgenic mice
expressing PrP proteins deleted of specific domains exhib-
ited major neurodegeneration (4,5) supports this view. Its
neuroprotective effect against oxidative stress has been re-
peatedly demonstrated in cell studies (6–8) and, interest-
ingly, the only obvious phenotype of PrP-null mice is their
higher sensitivity to conditions known to generate oxidative
stress including hypoxia (9) and ischemia (10). Several, non-
exclusive, hypotheses to explain this protective effect have
been proposed: antioxidant activity, metal homeostasis and
apoptosis regulation (1,11). However, although DNA is a
major target for reactive oxygen species induced toxicity
and expression of PrP was shown to protect human neu-
ronal cells against DNA damage, both under basal condi-
tions and following exposure to oxidative stress (12,13), one
possibility that to our knowledge has never been explored is
that PrP could have a direct role in DNA repair. Oxidative
DNA damage is the most frequent type of lesion formed in
DNA and it includes modified bases, apurinic/apyrimidinic
(AP) sites and single strand breaks, all of them substrates of
the base excision repair (BER) pathway (14). A major player
in this pathway is the AP endonuclease APE1. Knockout of
Ape1 in mice causes embryonic lethality (15,16) and APE1-
knockdown in cells triggers cell death (17). Studies on mice
heterozygous for the Ape1 gene show that the level of APE1
is critical for the cell response to genotoxic stresses (16,18).
In particular, APE1 DNA repair activity is crucial for the
survival of neuronal cells subjected to oxidative stress (19–
21).
Thus, to address the question of a role for PrP in
DNA damage repair in neuronal cells, we explored whether
changes in PrP levels could have an effect on the regulation
of BER either on unstressed cells or in cells exposed to a
genotoxic challenge by methyl-methane sulfonate (MMS),
a compound that reacts with DNA directly avoiding the
pleiotropic effects of an oxidative stress. We show here that
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PrP expression is induced and the protein stimulates APE1
enzymatic activity in the nucleus of cells exposed to geno-
toxic insult, thereby conferring resistance to the stress.
MATERIALS AND METHODS
Animals
Mice were bred and maintained according to the guide-
lines for the care and use of laboratory animals of the
French Ministry of Agriculture. The Prnp−/− mice (22,23),
which had a genetic background derived from 129/Sv
and C57BL/6J, have been back-crossed for 13 genera-
tions and then cross-bred to obtain a pure C57BL/6N ge-
netic background. Wild-type C57BL/6N mice (Prnp+/+)
were obtained from Harlan. The effect of MMS was stud-
ied on brains of 10-week-old animals sacrificed 24 h af-
ter intraperitoneal injection of vehicle dimethyl sulfoxide
(DMSO) or MMS. Brains were collected and cut in half
along the midsagittal plane. From one half 20% (w/v) ho-
mogenates were prepared for biochemical studies in 5% ster-
ile glucose by using a RiboLyser (Bio-Rad). The other half
was fixed by immersion overnight at 4◦C in 10% neutral
buffered formalin and processed for paraffin embedding us-
ing a Tissue-tek VIP processor (Leica). Five micrometer
coronal (hippocampus) sections were then obtained with a
microtome (RM 2125 RT, Leica) and mounted onto glass
slides. Sections from, Prnp−/−, Prnp+/+ control and treated
with MMS were mounted on the same slide and used for
confocal and immunohistological analysis.
Cell culture and genotoxic treatments
The immortalized murine hippocampal Prnp−/− cell line
HpL3–4 (22) was stably transfected via retroviral expression
vectors expressing or not mouse Prnp. Cells were grown in
OptiMEM-Glutamax (Gibco) supplemented with 10% fe-
tal calf serum (FCS) and antibiotics. The human neuroblas-
toma SH-SY5Y cell line was grown in DMEM-Glutamax
(Gibco) with 10% FCS and antibiotics. Primary cultures
of neural stem and progenitor cells were prepared from
freshly dissociated subventricular zone of ‘wild-type’ or
Prnp−/− mouse brains. Cells were plated in laminin-coated
(Sigma) 12-well plates and cultured in Neurocult complete
medium (StemCell) supplemented with heparin (2 g/ml),
epidermal growth factor (EGF) (20 ng/ml; Invitrogen) and
FGF2 (10 ng/ml; Invitrogen) as previously described (24).
For MMS treatments, cells were incubated for 1 h at 37◦C
in complete medium with various concentration of MMS.
Cells were then washed and returned to the incubator in
fresh medium for the indicated recovery periods. When indi-
cated, actinomycin D was added at a final concentration of
5 g/ml 1 h before MMS treatment and maintained there-
after during the treatment and the recovery period. Ox-
idative stress was induced by incubating cells for 24 h in
medium containing hydrogen peroxide at the indicated con-
centrations.
Cell viability was measured by cell counting using the
Countess automatic cell counter (Invitrogen) after trypan
blue staining and by the neutral red methods. Cells were in-
cubated for 1 h at 37◦C in medium containing 0.07% (w/v)
of red neutral dissolved in cell culture medium, washed
twice with Dulbecco’s Phsophate-Buffered Saline (DPBS).
Cell lysis was then performed by adding 1% acetic acid, 50%
ethanol solution and the optical density was measured at
540 nm.
Plasmids and expression of recombinant proteins
Full-length recombinant PrP (ovine and human), ovine
N-terminal mutant (PrP23-124) and N-terminus deletion
(PrP103-232) mutant were produced and purified as de-
scribed (25). None of the purified PrP preparations pre-
sented an intrinsic AP endonuclease activity (Supple-
mentary Figure S5A). The constructs pGex3X-hAPE1,
pGex3X-N33hAPE1 and pGex3X-hAPE1K5 mutant
(K24A, K25A, K27A, K31A, K32A) and their purification
were described elsewhere (26). XRCC1-purified recombi-
nant human protein was obtained as previously described
(27).
Transfections
Transfections of SH-SY5Y with empty pcDNA3 or
pcDNA3 MoPrP were done 24 h before treatment of
cells with MMS following a standard Lipofectamine 2000
protocol (Invitrogen). siRNA corresponding to the hu-
man PRNP gene was synthesized by Eurogentec. The
specific human siRNA sequence used was: 5′-GCC-
GAG-UAA-GCC-AAA-AAC-CTT-3′ (sense). A scramble
siRNA sequence (5′-CCG-AGA-AGU-AAA-GCC-AAC-
CTT-3′) was used as control. Cells were grown for 24 h be-
fore being transfected with the siRNA sequences using the
siRNAmax reagent (Invitrogen). They were allowed to grow
for 48 h before genotoxic treatments.
Western blot analysis
The 20 000 x g cell extracts were obtained by sonication
of cell pellets or brain homogenates in 20-mM Tris-HCl,
pH 7.5, 250-mM NaCl, 1-mM ethylenediaminetetraacetic
acid containing a cocktail of protease inhibitors: apopro-
tein, antipain and leupeptin (0.8 g each). The homogenate
was centrifuged at 20 000 x g for 30 min and aliquots of
the supernatant were stored at −80◦C for biochemical as-
says. Fifty microgram of total proteins from cells extracts
and 5 g of total proteins from brain extracts were loaded
and resolved by sodium dodecyl sulphate-polyacrylamide
gel electrophoresis (SDS-PAGE) and probed for detection
of PrP with primary monoclonal antibodies SAF70 for cells
extracts or SAF83 for brain extracts (Jacques Grassi, CEA
Saclay). APE1 detection was done as described (28). ß actin
(1/1000 Sigma) or vinculin (1/4000 Abcam) detection was
used as a control for protein loading. Secondary antibod-
ies coupled with horseradish peroxidase (Amersham) were
used at 1/30 000. Detection was performed using ECL-
advance Kit (Amersham).
AP endonuclease activity
AP endonuclease activity was measured using a 34-
mer oligonucleotide containing a single tetrahydrofuranyl
residue at position 16 and labeled as described (26). The
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Figure 1. DNA repair is impaired in the brain from Prnp−/− mice. (A–D) Results obtained on brain samples 24 h after in vivo MMS treatment of Prnp+/+
and Prnp−/− mice as compared to untreated mice. (A) APE1 endonuclease activity and (B) number of AP sites. Individual values as well as the median
(bold line) are shown. (*P < 0.05; **P < 0.01). (C) Western blot showing the levels of PrP and APE1 proteins after MMS treatment. ßactin was used
as loading control. (D) Increase in PrP immunohistochemical staining of the hippocampus of Prnp+/+ animals treated with MMS (100 mg/kg). (E) PrP
expression is induced in primary cultures of neural stem and progenitor cells 24 h after 1 h of treatment with 2-mM MMS. Equivalent cultures obtained
from Prnp−/− animals were used as a negative control. (F) Increased apoptosis as measured by TUNEL assay on neural and progenitor cells from Prnp−/−
animals 6 h after 1-h exposure to MMS at the indicated concentrations. One thousand cells were analyzed for each point: *P < 0.05; **P < 0.01; ***P <
0.001.
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Figure 2. PrP expression in hippocampal cells from Prnp−/− mouse im-
proves DNA repair and cell survival after genotoxic stress. (A) Western
blot showing the levels of PrP and APE1 proteins in HpL3–4 cells stably
expressing PrP (HpL-PrP) compared to cells carrying the empty vector
(HpL-EM), 24 h after 1-h exposure with 2-mM MMS. Vinculin was used
as loading control. (B) Number of AP sites in untreated (Ctl) and at 0,
1, 2 and 4 h following treatment with 2-mM MMS in HpL-EM and HpL-
PrP cells. Mean ± SD (n = 3). (C) APE1 endonuclease activity in untreated
(Ctl) and at 0, 2 and 4 h following treatment with 2-mM MMS in HpL-EM
and HpL-PrP cells. Mean ± SD (n = 3). (D) Cell survival as determined
by the red neutral assay for HpL-PrP cells compared to HpL-EM cells, 24
h after 1-h exposure with MMS. Mean ± SD (n = 8); *P < 0.05; **P <
0.01.
same protocol was used to study the in vitro APE1 stimula-
tion, except that recombinant proteins and the fluorescent
tetrahydrofuran-containing oligonucleotide were incubated
for 15 min on ice before starting the reaction.
Quantification of DNA damage
Genomic DNA from MMS-treated or untreated cells was
prepared using the QiAmpR DNA Kit (Qiagen). AP sites
were then measured using the DNA Damage Quantifica-
tion kit (AP sites) from Dojindo Molecular Technologies
according to the manufacturer’s specifications. To validate
the test, the levels of AP sites were determined in cells ex-
posed to increasing concentrations of MMS (Supplemen-
tary Figure S1A, left panel). To rule out a significant ef-
fect of the 10-min heating step in generating additional AP
sites by depurination of the alkylated bases, we compared
the yield of AP sites in DNA from MMS-treated cells ob-
tained by DNAzol (Life Technologies) including or not a
10-min heating step at 56◦C (Supplementary Figure S1A,
right panel). No significant differences were observed in the
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Figure 3. Downregulation of PRNP leads to blockage of DNA repair and
decreased survival of neuronal cells after genotoxic stress. (A) PrP levels
are induced after MMS treatment. Western blot for PrP and APE1 pro-
teins in cell extracts from SH-SY5Y cells transfected with siRNA PrP or
with the scramble siRNA after 24 h recovery in fresh medium following
1-h treatment with 1.5-mM MMS. ßactin was used as loading control. AP
endonuclease activity (B) and AP sites (C) in SH-SY5Y expressing the indi-
cated siRNAs and treated or not (Ctl) with 1.5-mM MMS. Mean ± SD (n
= 3); **P < 0.01. ***P < 0.001. (D) PrP-depletion sensitizes cells to MMS.
SH-SY5Y cells transfected with a siRNA PrP or a scramble siRNA were
treated for 1 h with MMS and cell survival was measured after 24 h of re-
covery. Mean ± SD (n = 8); **P < 0.01; ***P < 0.001. (E) PrP-depletion
sensitizes cells to H2O2. SH-SY5Y cells transfected with siRNA PrP or a
scramble siRNA were treated with H2O2 and cell survival was measured
24 h later. Mean ± SD (n = 5); *P < 0.05; ***P < 0.001. (F) APE1 en-
donuclease activity in extracts from SH-SY5Y cells 24 h after treatment
with 0.5- or 0.75-mM H2O2. Mean ± SD (n = 3); **P < 0.01. (G) West-
ern blots for PrP and APE1 proteins in cell extracts from SH-SY5Y cells
transfected with siRNA PrP or a scramble siRNA after 24 h of treatment
with H2O2. ßactin was used as loading control.
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with or without a heating step for the MMS concentrations
≤2 mM used for the rest of the experiments.
Reverse transcription and QPCR
Total RNA was prepared from frozen cell pellets using
RNeasyR Plus kit (QIAGEN) and quantified by Nanodrop
spectrophotometer. For the first strand cDNA synthesis
500 ng of total RNA was reverse-transcribed using Super-
ScriptVILO cDNA synthesis kit (Invitrogen, Cergy Pon-
toise, France). Quantitative PCRs were performed with
an ABI PRISM 7300 sequence detection system (Applied
Biosystems) by using the TaqMan Universal PCR Master
Mix (Applied Biosystems). Quantification of each gene ex-
pression was calibrated using a reference standard curve ob-
tained by serial dilutions of PCR product prepared from a
control cDNA. The mean expression of rplpo (large ribo-
somal protein gene) was used to normalize the expression
of PRNP gene. PRNP was amplified by PCR primers pur-
chased from Applied Biosystems (Hs01920617-s1).
Immunofluorescence and confocal microscopy
For cellular analysis, cell cultures were grown on 12-mm
coverslips. After the treatments they were fixed with 4%
formaldehyde and, unless indicated, permeabilized in phos-
phate buffer saline (PBS), 0.1% Triton X-100 for 2 min
at room temperature. After 10 min of blockage in PBS,
1% bovine serum albumin (BSA), they were incubated
with mouse anti-PrP (SAF37 recognizing epitopes 79–92
or SAF70 recognizing epitopes 142–160), rabbit anti-APE1
(28) or rabbit anti-Histone H4 Lys12 (Santa Cruz). Alexa
594-coupled and Alexa 488-coupled secondary antibodies
(Life technologies A11005 and A11008) were then used.
Coronal sections (5 m) of adult brain hippocampus
were mounted onto glass slides and treated successively
with xylene, ethanol in decreasing concentrations and wa-
ter. Slides were then microwaved (620 W) twice for 10 min
in 10-mM citrate buffer. After washing with water the slides
were treated for 1 h at room temperature with a solution
containing 10% sodium lauroyl sarcosinate, 10% Triton and
2-M urea. After 1-h blockage in PBS containing 15% fetal
bovine serum, the tissue was stained with a rabbit mono-
clonal antibody against PrP (Epitomics, clone EP 1802Y)
and Alexa 488-coupled secondary antibodies (Molecular
Probes).
Coverslips were mounted in Vectashield hard
setTM mounting medium containing 4′,6-diamidino-2-
phenylindole (DAPI) (Vector). Image acquisition was
performed with a Leica TCS SPE confocal microscope.
Images were processed and analyzed using Image J
software.
TUNEL assay
For TUNEL studies primary neuronal cells obtained
from Prnp+/+ and Prnp−/− animals grown on Lab-Tek
(Dutscher) were treated for 1 h with 1, 2 or 3-mM MMS,
washed with culture medium and returned for 6 h in the
incubator at 37◦C. They were then fixed for 10 min in 4%
paraformaldehyde and permeabilized in PBS containing
0.1% Triton X-100 for 10 min. After a wash in PBS, cells
were incubated in the dark for 1 h at 37◦C, with the enzyme
and the label solution provided by the ‘In Situ Cell Death
Detection Kit, Fluorescein’ (Roche Diagnostic). Nuclear
staining was achieved by incubation with DAPI. Slides were
mounted under Fluoromount (Southern Biotechnologies
Associates). Apoptosis was measured by counting TUNEL
positive cells visualized by fluorescence microscopy. For
each point a minimum of 1000 cells were analyzed.
Proximity ligation assays
To detect protein–protein interactions, in situ proximity lig-
ation assays (PLAs) (29) were performed using Duolink II
secondary antibodies and detection kit (Olink Bioscience)
according to the manufacturer’s instructions. The specificity
of this assay was assessed by using the secondary antibod-
ies alone. No signal was detected (data not shown). The
specificity of the staining was also confirmed by the lack
of staining of PrP/APE1 in unstressed SH-SY5Y cells, (see
Figure 6A, upper panels) and by the absence of staining of
PrP/XRCC1 in MMS-treated cells (Supplementary Figure
S4) (XRCC1 antibody was from Abcam). Images were ac-
quired on a Leica TCS SPE confocal microscope and ana-
lyzed using Image J software.
Glutathion S-Transferase (GST) pull-down assay
Beads were first saturated with bait proteins by incubating 1
nmol of GST-APE1 or GST alone on 10 l of glutathione-
Sepharose 4B beads (GE Healthcare). Beads were washed
four times in PBS, then 150 g of a protein extract from
MMS-treated SH-SY5Y cells was added and incubated for
2h at 4◦C under gentle rocking. Beads were washed four
times with PBS and then boiled in 1× Laemmli sample
buffer containing 100-mM Dithiothreitol (DTT). Samples
were separated on SDS-PAGE gels before western blotting.
Immunoprecipitation
5.106 MMS-treated or untreated SH-SY5Y cells were resus-
pended in 500 l buffer A (150-mM Tris-HCl, pH 7.5, 150-
mM NaCl, 0.5% Triton X-100, 1-mM MgCl2 and protease
inhibitors) and incubated for 15 min at 4◦C on a rotating
shaker. After 20-min centrifugation at 15 000 x g at 4◦C,
the supernatant was collected and incubated for 1 h at 4◦C
on a rotating shaker with 0.5-g mouse IgG anti-PrP mon-
oclonal antibody (SAF70, SAF37) or non-specific mouse
control IgG. The immunocomplexes were then isolated us-
ing anti-mouse IgG Dynabeads (Invitrogen) according to
the manufacturer’s instructions and resuspended in 25-l
buffer A. Four microliters were kept for APE1gel cleav-
age assay and the remaining volume was boiled in Laemmli
sample buffer and analyzed by SDS-PAGE electrophoresis
and western blot as described.
Immunohistochemistry
After paraffin removal, tissue sections were boiled in a 10-
mM citrate solution (pH6), washed in PBS and then incu-
bated for 10 min in PBS, 1% SDS. After saturation for 30
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min in PBS, 2% BSA, tissue sections were incubated for
45 min at 37◦C with the monoclonal antibody Bar233 at
1:500 (Jacques Grassi, CEA Saclay) and washed in PBS, 2%
BSA. Primary antibodies were revealed using IMPRESS
anti-mouse Ig Polymer detection kit (Vector Laboratories)
and counterstained with hematoxylin (Labonord). Pictures
were recorded using a BX51 Olympus microscope coupled
with a color video camera (Sony) and the Histolab software
(Microvision Instruments, Evry, France).
Statistical analysis
Mann–Whitney statistical analysis was performed using the
BioStaTGV online software.
RESULTS
In brain tissues, APE1 activity and DNA repair induction by
a genotoxic stress are dependent on PrP induction
In order to explore the possibility of a link between PrP
and DNA repair we compared the response of brain from
wild-type and Prnp−/− mice to methyl-methanesulfonate
(MMS), an alkylating agent that leads to high levels of
AP sites in cellular DNA. MMS was chosen to avoid the
pleiotropic effects and responses triggered by an oxidative
stress. Animals were injected with MMS and the AP en-
donuclease activity was measured in brain homogenates 24
h after the treatment (Figure 1A). Interestingly, the basal
levels of AP endonuclease activity were significantly lower
in brain extracts from Prnp−/− animals than in those from
the wild type. Moreover, while an induction of the activity
was detected after MMS treatment of wild-type animals,
this increase was completely absent in the Prnp−/− ones.
Consistent with a compromised DNA repair capacity, the
unrepaired AP sites remaining in the brain 24 h after the
treatment were higher in the Prnp−/− brain cells than in
those from wild-type animals (Figure 1B).
Figure 1C and Supplementary Figure S1B show that in
spite of the higher Ape1 activity detected in the brains of
wild-type animals, there was no correlation between the lev-
els of Ape1 protein and the Prnp genotype, neither at the
basal level nor after MMS injection. Surprisingly, evalua-
tion of PrP protein levels in the same extracts showed a clear
induction of PrP in response to the MMS injection (Figure
1C). The increase in PrP in response to the MMS injection
was further confirmed by immunohistochemistry of the hip-
pocampus (Figure 1D).
Taken together, these results indicate that PrP expression
is induced in mouse brain in response to MMS and that this
induction is required for an increase in AP endonuclease ac-
tivity and a more efficient DNA damage repair in brain.
PrP levels determine neuronal cells DNA repair capacity and
survival to genotoxic agents
We reasoned that if the PrP deficiency in mice resulted in an
impaired DNA repair capacity, it should also sensitize brain
cells to the genotoxic insult. To test this hypothesis we iso-
lated neural stem and progenitor cells from either wild-type
or Prnp−/− animals. Exposing these cells in primary culture
to MMS triggered the induction of the PrP protein (Figure
1E). Moreover, Prnp−/− neuronal stem and progenitor cells
displayed significantly higher levels of apoptotic cells than
wild type (Figure 1F), indicating that PrP has a protective
function against the DNA damaging agent.
To further define the relationship between the expression
of PrP and the repair of abasic sites in mouse neurons, we
compared the response to MMS of hippocampal HpL3–4
Prnp−/− cells expressing PrP (HpL-PrP) or not (HpL-EM)
from a constitutive promoter. As observed in brain tissues,
even though the levels of APE1 protein did not vary (Figure
2A), after exposure to the alkylating agent cells lacking PrP
showed higher levels of induced AP sites than those express-
ing the protein (Figure 2B). Furthermore, HpL-EM cells
displayed an impaired repair capacity compared to that of
cells expressing PrP (Figure 2B). Consistent with this obser-
vation, APE1 activity was readily induced after MMS treat-
ment in HpL-PrP but not in HpL-EM cells (Figure 2C).
In order to confirm that the deficiency in repair detected
in cells lacking PrP had consequences on their resistance to
the alkylating agent, we monitored cell survival after expo-
sure to MMS. We found that the PrP deficiency led to a sen-
sitization of HPL-EM cells to the genotoxic agent (Figure
2D).
We then analyzed the correlation between PrP expres-
sion, AP site repair capacity and cell survival in the hu-
man neuroblastoma cell line SH-SY5Y. First, we attempted
reducing the PrP cellular content by a siRNA approach.
Treatment of the cells with the alkylating agent strongly
induced the expression of PrP in cells transfected with
the control siRNA (siRNA-Scr), whereas expression of the
siRNA against PRNP (siRNA-PrP) blocked this induction
(Figure 3A, upper panel). As observed in mouse brains, the
increase in PrP levels in response to MMS was paralleled
by the induction of the AP endonuclease activity, which
was also blocked in cells expressing siRNA-PrP (Figure
3B). In spite of the increased activity in SH-SY5Y-siRNA-
Scr cells exposed to MMS, no significant variations in the
levels of the APE1 protein could be observed (Figure 3A,
lower panel). In agreement with the blockage of the induc-
tion of APE1 activity, SHSY5Y-siRNA-PrP cells displayed
a strong inhibition of AP sites repair (Figure 3C). The ap-
parently slow repair observed as well as the continuing ac-
cumulation of damage suggests that significant amounts
of MMS remain within the cell after the medium change.
Moreover, the lack of PrP induction in SH-SY5Y-siRNA-
PrP cells greatly impaired their survival following exposure
to the alkylating agent (Figure 3D). To confirm the corre-
lation between PrP levels and the DNA damage response
(DDR), we took the complementary approach to the above
experiments by stably overexpressing PrP in SH-SY5Y cells
(Supplementary Figure S2A). Higher PrP levels did indeed
result in an improved cell survival at high MMS concentra-
tion (Supplementary Figure S2B).
Because APE1 is the first common enzyme in the BER
pathway, we reasoned that PrP could also regulate the cel-
lular response to other kinds of genotoxic agents. In par-
ticular we were interested in analyzing a putative role of
PrP in the regulation of APE1 activity in cells subjected
to an oxidative stress. Confirming the protective effect of
PrP in neurons exposed to oxidative conditions, we found
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an enhanced sensitivity of SH-SY5Y-siRNA-PrP cells com-
pared to those expressing the control siRNA after exposure
to hydrogen peroxide (Figure 3E). Interestingly, exposure
to H2O2 induced the APE1 activity in SH-SY5Y-siRNA-
Scr cells, whereas inhibiting PrP expression in SH-SY5Y-
siRNA-PrP cells abolished the induction of the AP endonu-
clease activity (Figure 3F). Oxidative treatment led to in-
creased levels of PrP protein in the siRNA-Scr-transfected
cells, whereas expression of APE1 remained unchanged
(Figure 3G).
These results show that PrP is crucial in human and
mouse neuronal cells to induce APE1 activity in response
to genotoxic insult, including oxidative stress, thus allow-
ing the repair of induced DNA lesions and cell survival.
Genotoxic stress leads to transcriptional activation of PRNP
The results obtained on brain (Figure 1C) and cell cultures
(Figure 3A and G) showed an increase of PrP protein levels
in response to DNA damaging agents. Since such an induc-
tion was not observed in the HpL-PrP cells where PRNP
is expressed from a constitutive promoter (Figure 2A), we
hypothesized that the endogenous PRNP promoter could
be activated in response to the treatment. Quantitative RT-
PCR analyses done on both SH-SY5Y-siScr and -siPrP cells
at different times after exposure to either MMS (Figure 4A)
or H2O2 (Figure 4B) showed a strong increase in PRNP
transcripts in response to the genotoxic stresses, leading to
a higher PrP cellular content (Figures 3G and 4C). For both
genotoxic treatments, the induction of PRNP mRNA and
protein levels was efficiently blocked by the siRNA against
PrP (Figures 3G and 4C). Confirming that the increase in
PRNP mRNA levels after MMS treatment is due to an ac-
tivation of the PRNP promoter, we observed that actino-
mycin D completely blocked the induction in the PRNP
mRNA levels in MMS-treated cells (Figure 4D).
PrP is found in the nucleus after genotoxic stress
Since in all cases presented above PrP induction in response
to a genotoxic stress resulted in a stimulation of APE1 ac-
tivity without a significant increase in APE1 protein levels
(Figures 1C, 3A and G), we reasoned that PrP could interact
functionally with APE1. However, while APE1 acts essen-
tially in the nucleus, PrP is generally found as a membrane-
associated protein, although its presence in the nucleus has
been reported (30–33). We therefore decided to analyze by
confocal microscopy the PrP subcellular localization in the
brain from mice exposed to MMS. While no signal is de-
tected in Prnp−/− (Figure 5A, upper panels), a specific la-
beling is observed in the hippocampus of wild-type-non-
treated animals (Figure 5A, middle panels). However, 24 h
after intra-peritoneal MMS injection, not only a clear in-
crease in PrP levels but also an unambiguous nuclear local-
ization of the protein was revealed in the same region of the
brain (Figure 5A, lower panel).
To verify that PrP accumulated also in the nuclei of hu-
man SH-SY5Y neuroblastoma cells treated with a geno-
toxic agent, we analyzed the localization of the protein by
immunofluorescence (IF) using two monoclonal antibod-
ies against different PrP epitopes. As shown in Figure 5B,
Figure 4. Genotoxic stress induces increased PrP protein levels through
transcriptional activation of PRNP. (A) PRNP transcripts are induced af-
ter MMS treatment. RT-PCR analysis of PRNP mRNAs in SH-SY5Y cells
transfected with siRNA PrP or with the scramble siRNA at different times
following treatment with 1.5-mM MMS compared to untreated cells (Ctl)
Mean ± SD (n = 4). (B) PRNP transcripts are induced after H2O2 treat-
ment RT-PCR analysis of PRNP mRNAs in SH-SY5Y cells transfected
with siRNA PrP or with the scramble siRNA at 24 h following treatment
with 0.5- and 0.75-mM H2O2 compared to untreated cells (Ctl). Mean
± SD (n = 4). (C) PrP protein levels are induced after MMS treatment.
Western blots for PrP at different times following 1-h exposure to 1.5-mM
MMS of SH-SY5Y cells transfected with siRNA PrP or with the scram-
ble siRNA. (D) Actinomycin D prevents the induction of PRNP mRNA
in MMS-treated cells. RT-PCR analysis of PrP mRNAs in untreated SH-
SY5Y cells or 4 h after exposure to 1.5-mM MMS in the presence or ab-
sence of actinomycin D.
PrP expression was highly increased after MMS exposure
and, in addition to the classic membrane localization, we
detected a strong signal for PrP in nuclei, where APE1 was
also found. Because the presence of PrP in the nucleus was
unexpected, we wondered whether the failure to detect a
nuclear signal by IF in previous reports could, in part, be
due to differences in the protocols used. Indeed, since de-
tection of external membrane proteins does not require in-
ternalization of the antibodies for their recognition, most
IF studies aiming at visualizing PrP do not include the per-
meabilization step. Figure 5C shows that the classic PrP lo-
calization pattern is indeed obtained in MMS-treated cells
by omitting permeabilization. However, under those con-
ditions even abundant nuclear proteins such as histone H4
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Figure 5. Genotoxic stress leads to accumulation of PrP in the nucleus of neuronal cells. (A) Increase of nuclear PrP in brain sections from Prnp+/+ mice
24 h after MMS treatment (100 mg/kg) as detected by immunofluorescence. Brain sections from Prnp−/−/ animals were used as negative control. (B)
Images obtained by confocal microscopy showing PrP and APE1 staining in SH-SY5Y cells 24 h after 1 h of treatment with 1.5-mM MMS as compared
to untreated ones. Two different antibodies recognizing different epitopes of PrP were used: SAF70 (left panel) and SAF37 (right panel). (C) Detection
of nuclear PrP requires permeabilization of the cells. PrP (SAF37 antibody) and histone H4 staining was performed on non-permeabilized (left panel) or
permeabilized (right panel) control and MMS-treated SH-SY5Y cells.
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Figure 6. PrP interacts with APE1 and stimulates its endonuclease activity. (A) PLA assay shows the in situ close proximity of endogenous PrP and APE1
(red spots) mainly in cell nuclei (DAPI) at 4 and 24 h after MMS treatment of SH-SY5Y cells. (B) Protein extracts from SH-SY5Y cells treated with
1.5-mM MMS were subjected to GST-pull down assays using GST or GST-APE1. (C) Protein extracts from SH-SY5Y cells untreated or treated with
1.5-mM MMS were subjected to immunoprecipitation with antibodies against PrP and APE1 was detected by western blot (upper panel). Lanes IG and
MW correspond to a non-specific antibodies and molecular weight markers, respectively. The presence of APE1 in the immunoprecipitate was also probed
through an enzymatic activity assay by evaluating the conversion of the fluorescent tetrahydrofuran-containing oligonucleotide substrate (S) to the shorter
incised product (P) (lower panel). (D) Representative gel showing the stimulation by human recombinant PrP (rhPrP) of the AP endonuclease activity
of extracts from Prnp−/− brain and cells (20ng). Panel (C) corresponds to the oligonucleotide without any protein added. (E) Stimulation by rhPrP or
rhXRCC1 (2 pmoles) of the endonuclease activity of purified human APE1.






10 Nucleic Acids Research, 2014
Figure 7. PrP-mediated stimulation of APE1 endonuclease activity involved the N-terminal part of each protein. (A) Stimulation by rhPrP of the endonu-
clease activity of the human wtAPE1, N33APE1 and K5AAPE1. (B) Stimulation of the endonuclease activity of rhAPE1 (0.2 fmoles) or Prnp−/− cell
extracts (20 ng) by the indicated amounts of ovine wtPrP, Nter (AA 103–232) and Nter (AA 23–124). For (A) and (B), data correspond to the average of
three independent experiments. Representative activity gels are presented in each case (right panels).
are inaccessible to antibodies (Figure 5C, left panel). It is by
adding the permeabilization step that nuclear proteins, such
as the histone and the PrP nuclear fraction, can be detected
(Figure 5C, right panel). Finally, to rule out that the nu-
clear signal observed was due to the internalization of the
membrane-associated protein during the permeabilization
procedure, SH-SY5Y cells exposed to MMS were treated
with phosphoinositide phospholipase C (PIPLC) prior to
PrP staining in order to eliminate the PrP present on the
cell surface by cleavage of the protein from its GPI anchor.
While in non-permeabilized cells treated with PIPLC essen-
tially all the detectable PrP signal was lost, permeabilization
allowed us to unambiguously detect the intracellular PrP
fraction, in particular in the nucleus (Supplementary Figure
S3A). The presence of PrP in the nucleus was further con-
firmed by subcellular fractionation of SH-SY5Y cells (Sup-
plementary Figure S3B).
PrP interacts with APE1 and stimulates its DNA repair ac-
tivity
We then addressed the possibility of a physical interaction
between PrP and APE1. PLAs (29) showed that after MMS
exposure PrP and APE1 are found within interaction dis-
tance from each other mainly in the nucleus (Figure 6A).
Whereas a positive signal was found using XRCC1 and
APE1, a known APE1 interactor (34), no signal of prox-
imity was observed between PrP and XRCC1, confirming
the specificity of the PLA assay using APE1 and PrP af-
ter genotoxic stress (Supplementary Figure S4). These re-
sults raised the possibility that stimulation of APE1 by PrP
is the result of a direct interaction between the two proteins.
GST pull-down experiments using a GST-APE1 fusion pro-
tein as bait confirmed this interaction in extracts from cells
exposed to MMS (Figure 6B). The reciprocal experiment,
immunoprecipitation of PrP, confirmed that active APE1 is
specifically associated with the prion protein after genotoxic
stress, as shown both by immunoblot against APE1 (Fig-
ure 6C, upper panel) and AP-endonuclease assays (Figure
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6C, lower panel). To definitely assess the impact of PrP on
APE1 activity, purified human recombinant PrP was added
to AP endonuclease activity reactions with either Prnp−/−
cell extracts or Prnp−/− brain homogenates. In both cases
addition of recombinant PrP significantly increased AP en-
donuclease activity (Figure 6D). Control experiments with
PrP alone demonstrated that the PrP protein itself has no
AP-site incision activity (Supplementary Figure S5A). The
stimulation of APE1 by PrP was further confirmed by mea-
suring the activity of purified human APE1 in the pres-
ence of recombinant PrP. The stimulation of APE1 by PrP
was comparable to that obtained with XRCC1, previously
shown to be an inducer of APE1 endonuclease activity (34)
(Figure 6E). Taken together these results confirm that PrP
can directly stimulate the major AP endonuclease APE1.
Since stimulation of APE1 by several of its partners is
mediated by the N-terminal domain of the protein through
the presence of charged lysines (26), we asked whether these
residues were also involved in the stimulation of APE1 ac-
tivity by PrP. APE1 stimulation by PrP was abrogated by
deletion of the first 33 amino acids of APE1 (N-33) or
mutation of its first five lysines into alanines (K5A) (Fig-
ure 7A). Similar results were obtained using recombinant
ovine PrP (Supplementary Figure 5B). Based on the fact
that the N-terminal part of PrP was shown to mediate its
neuroprotective effect (35,36), we then checked if this region
is also involved in the stimulatory effect on APE1 activity.
We found that the N-terminal region is sufficient for stimu-
lation of APE1 repair activity, whereas PrP deleted from its
N-terminal part (Nter) is ineffective (Figure 7B).
DISCUSSION
PrP is a highly conserved protein predominantly expressed
in neurons. Here, we have unveiled a major role for PrP
in the maintenance of genomic stability after exposure to
a genotoxic stress both in cultured neuronal cells and in
mouse brain. Thus, our findings provide a new explanation
for the previously described protective effect of PrP against
oxidative conditions found both in vitro and in vivo. This
novel function of PrP could be critical for limiting the long-
term accumulation of DNA damage in neurons, consistent
with the high level of basal expression of PrP in these spe-
cific cells that need to survive for decades.
We show here that an early event characterizing the pro-
tective effect of PrP is upregulation of PRNP gene expres-
sion. PRNP transcriptional activation was previously re-
ported in neuronal cells exposed to oxidative stress condi-
tions (37,38). Our results not only confirm these data but
also show for the first time that PRNP gene expression
is rapidly upregulated after exposure to MMS, suggesting
that PRNP is involved in the DDR. This is consistent with
the observed transcriptional activation of PRNP involv-
ing the ataxia telangiectasia-mutated (ATM) pathway after
a copper-induced oxidative stress (38). Interestingly, ATM
signaling is known to be triggered by MMS-induced DNA
damage (39) and to activate BER (40) after exposure of cells
to the alkylating agent. These observations together with
the results presented here further support the involvement
of PrP in the DDR.
We show here that PrP interacts with and stimulates
APE1, a central component of the BER system required for
the protection of neurons against oxidative stress (19–21).
In this way the induction of PrP boosts cell DNA repair ca-
pacity and favors survival to genotoxic stresses. Although
PrP is mainly considered a membrane-anchored protein,
there are evidences pointing to its presence in the nucleus
(30,31,33,41,42), thus potentially allowing an interaction
with APE1. The identification of several proteins with affin-
ity for nucleic acids as PrP interactors also suggested a
nuclear function for PrP (43). Notably, PrP interacts with
the N-methylpurine DNA glycosylase whose role is to re-
move alkylated bases, just upstream of APE1 in the BER
of MMS-induced DNA lesions. The idea of a role for PrP
in DNA repair is further supported by its affinity for nu-
cleic acids (44) and its capacity to bend and unwind DNA
(45,46). Moreover, it was recently demonstrated that it in-
teracts with chromatin histones (33,47). Our results raise
the question of how PrP, a protein normally going through
the glycosylation pathway, can, in response to a genotoxic
stress, be directed to the cell nucleus. Although the under-
lying mechanisms are still unclear, several groups have also
found that glycosylated forms of PrP are localized to the
cell nucleus (33,41,42). Consistently, cryptic nuclear local-
ization signal sequences in the C-terminal part of PrP have
been identified (48). Alternative mechanisms involving ret-
rograde intracellular transport (49–52) or internalization
(53) can also be invoked and should be explored. Thus, the
ability of PrP to be directed to the nucleus and modulate
DNA or chromatin structures is in agreement with a role
in the recruitment and activation of DNA repair proteins
inferred from our results.
We find here that the stimulation of APE1 activity by PrP
is mediated by the flexible N-terminal part of the protein.
Interestingly, the positively charged N-terminal domain of
PrP is required for its DNA binding activity (45,46) as well
as for its protective activity against stress (35). Moreover,
expression of a N-terminal truncated PrP in mice leads to
ataxia and cerebellar lesions, a phenotype that could be res-
cued by the introduction of a single copy of the wild-type
gene (4). More recently, it was reported that the N-terminal
domain of the protein is critical for its neuroprotective activ-
ity in mice (54), underscoring the importance of this domain
in PrP function.
Stimulation of APE1 endonuclease activity by PrP re-
quires the presence of five charged lysines within the first 33
amino acids of the N-terminal region of APE1, the same
region required for the stimulation by XRCC1 (34) and
NPM1 (26,28). These critical residues were shown to reg-
ulate APE1 catalytic activity on abasic DNA by stabilizing,
through electrostatic binding, the enzyme on the reaction
product (26).
Several observations suggest that the reduced APE1 ac-
tivity in Ape1 heterozygous mice and the impairment of
its induction in Prnp−/− mice share some common conse-
quences. Indeed, the 2-fold reduction in Ape1 activity due to
haploinsufficiency was found to be sufficient to alter DNA
repair efficiency and to increase cell death in mice sub-
jected to a genotoxic stress (18). Similarly, PrP-deficiency
and Ape1 haploinsufficiency each renders cells more sensi-
tive to apoptosis (55,56). Interestingly, as it is the case for
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Prnp−/− mice, Ape1 heterozygous mice, in spite of their re-
duced repair capacity, do not show any overt phenotype in
normal conditions nor do they display a predisposition to
cancer (16,18). The reduced APE1 activity in Ape1+/− mice
only favors cancer development in response to genotoxic
stress when combined with deficiencies in other DNA re-
pair or apoptosis pathways (57,58). Interestingly, a recent
report showed that animals genetically impaired for BER
of oxidative DNA damage show an accelerated progression
of prion-induced symptoms (59). This, together with the re-
sults presented here, raises the intriguing possibility that ag-
gregation of PrP during disease might lead to the loss of
the normal PrP role in activating DNA repair, accelerating
therefore neuronal cell death.
In conclusion, this study reveals a new physiological func-
tion of PrP as a strong activator of DNA damage repair
through stimulation of the central base excision repair en-
zyme, the AP endonuclease APE1. PrP would thus be re-
quired to maintain genetic stability in cells subjected to ei-
ther endogenous or exogenous stresses leading to increased
levels of ROS and thus to elevated generation of AP sites.
This function might be impaired in any pathology charac-
terized by PrP modifications and increased oxidative stress,
leading to accumulation of mutations or to cell death. Con-
sidering the ubiquitous expression of the PrP-encoding gene
in mammalian tissues, this DNA protection pathway is
likely to operate in cell types other than neurons.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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